Examining Strategy Monitoring and Remediation Training
Launched by UNIVERSITY OF TORONTO · Feb 11, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different types of training to help improve thinking skills in people with psychotic disorders, like schizophrenia. The study compares a full program that focuses on enhancing executive functions—skills that help us plan, make decisions, and control our impulses—with two other approaches: a basic computer training and a strategy monitoring method. The goal is to see which method works best in helping individuals manage their daily activities more effectively.
To join this study, you need to be between 18 and 65 years old and have a clinical diagnosis of schizophrenia, schizoaffective disorder, or another psychotic disorder. You should be comfortable using a computer and able to read and speak English. Participants will take part in training sessions and will likely have the chance to learn new skills in a supportive environment. It’s important to note that you cannot currently be in another cognitive training program or have certain medical conditions that could affect your brain function. This trial is currently recruiting participants, and everyone is welcome, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • clinical diagnosis of schizophrenia, schizoaffective disorder or any other psychotic disorder (based on DSM-V)
- • 18-65 years of age
- • know how to use a computer
- • not abusing drugs or alcohol
- • can read and speak English.
- Exclusion Criteria:
- • enrolled in a cognitive training program in the last 6 months
- • neurological disease or neurological damage
- • medical illnesses that can change neurocognitive function
- • medical history of head injury with loss of consciousness
- • physical handicaps
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Michael Best, PhD
Principal Investigator
University of Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials